Australia markets closed
  • ALL ORDS

    7,270.00
    +3.40 (+0.05%)
     
  • ASX 200

    7,068.80
    +3.60 (+0.05%)
     
  • AUD/USD

    0.6443
    +0.0026 (+0.40%)
     
  • OIL

    90.33
    +0.70 (+0.78%)
     
  • GOLD

    1,944.90
    +5.30 (+0.27%)
     
  • Bitcoin AUD

    41,256.09
    -95.84 (-0.23%)
     
  • CMC Crypto 200

    565.87
    -2.18 (-0.38%)
     
  • AUD/EUR

    0.6049
    +0.0036 (+0.60%)
     
  • AUD/NZD

    1.0810
    -0.0001 (-0.01%)
     
  • NZX 50

    11,372.62
    +53.88 (+0.48%)
     
  • NASDAQ

    14,701.10
    +6.85 (+0.05%)
     
  • FTSE

    7,683.91
    +5.29 (+0.07%)
     
  • Dow Jones

    33,963.84
    -106.58 (-0.31%)
     
  • DAX

    15,557.29
    -14.57 (-0.09%)
     
  • Hang Seng

    18,057.45
    +402.04 (+2.28%)
     
  • NIKKEI 225

    32,402.41
    -168.62 (-0.52%)
     

IQVIA Holdings (IQV) Surpasses Q1 Earnings & Revenue Estimates

IQVIA Holdings Inc. IQV reported solid first-quarter 2023 results, wherein earnings and revenues surpassed the Zacks Consensus Estimate.

Adjusted earnings per share of $2.45 beat the Zacks Consensus Estimate of $2.41 but declined on a year-over-year basis. Total revenues of $3,652 million outpaced the Zacks Consensus Estimate of $3,608.2 million and increased 2.4% year over year on a reported basis and 4.7% on a constant-currency basis.

IQVIA Holdings Inc. Price, Consensus and EPS Surprise

 

IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. Quote

Segmental Revenues

Revenues from Technology & Analytics Solutions totaled $1,444 million, up 0.3% on a reported basis and 2.9% on a constant-currency basis.

Research & Development Solutions’ revenues of $2,026 million increased 4.8% on a reported basis and 6.5% on a constant-currency basis.

Revenues from Contract Sales & Medical Solutions totaled $182 million, down 6.7% on a reported basis and 1% on a constant-currency basis.

Operating Performance

Adjusted EBITDA was $851 million, up 4.8% year over year.

Balance Sheet and Cash Flow

IQVIA exited first-quarter 2023 with cash and cash equivalents of $1,494 million compared with $1,216 million at the end of the prior quarter. Long-term debt (less current portion) was $11,833 million compared with $12,595 million at the end of the prior quarter.

IQV generated $417 million of cash from operating activities in the reported quarter, while capital expenditure was $164 million. Free cash flow was $253 million.

In the first quarter of 2023, IQV repurchased shares worth $129 million. As of Mar 31, 2023, IQVIA had $1,226 million of share repurchase authorization available.

2023 Guidance

IQVIA expects revenues between $15.15 billion and $15.40 billion (representing growth of 5.1-6.9% on a reported basis and 4.7-6.5% at constant currency).  Adjusted earnings per share are expected between $10.26 and $10.56 (up 1-3.9%). Adjusted EBITDA is anticipated between $3.625 billion and $3.695 billion.

Currently, IQVIA carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Earnings Snapshot

Equifax EFX reported better-than-expected first-quarter 2023 results. Adjusted earnings (excluding 52 cents from non-recurring items) were $1.43, beating the Zacks Consensus Estimate by 4.4% but declining 35.6% from the year-ago figure. Total revenues of $1.3 billion surpassed the consensus estimate by 1.5% but decreased 4.5% on a reported basis from the year-ago figure. The top line was down 3% on a local currency basis.

OmnicomOMC reported better-than-expected first-quarter 2023 results. OMC’s earnings of $1.56 per share beat the Zacks Consensus Estimate by 13% and our estimates by 11.4%. Earnings per share increased 12.2% year over year. Total revenues of $3.4 billion surpassed the consensus estimate by 2.3% and our estimate by 1.4%. The top line increased 1% year over year.

ManpowerGroupMAN reported lower-than-expected first-quarter 2023 results. First-quarter adjusted earnings of $1.61 per share lagged the consensus mark by 0.6% but met our estimate. The bottom line declined 14.4% year over year, impacted by restructuring costs and foreign currency fluctuations. Revenues of $4.8 billion missed the consensus mark by 1.3% and our estimate by a slight margin. The top line decreased 7.6% year over year on a reported basis. Revenues decreased 2.2% on a constant-currency basis.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ManpowerGroup Inc. (MAN) : Free Stock Analysis Report

Omnicom Group Inc. (OMC) : Free Stock Analysis Report

Equifax, Inc. (EFX) : Free Stock Analysis Report

IQVIA Holdings Inc. (IQV) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research